Search Browse Earnings

Cyclo Therapeutics, Inc. — SlamSEC

Cyclo Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)·GAINESVILLE, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$1.0M

+1.3% YoY

FY 2013

Adj. EBITDA

-$15.6M

-1493.1% margin

FY 2023

Net Income

-$15.5M

-1478.6% margin

FY 2023

EPS (Diluted)

-$1.83

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$1.5M

FY 2023

Total Debt

$929,169

FY 2014

Net Cash

$614,249

FY 2014

Enterprise Value

—

Debt / EBITDA

0.0x

FY 2013

EV / EBITDA

—

Employees

—